Showing results (11-20 of 540) with videos related to

Sort By:
Pageof 54
Drugs - Real World Outcomes|July 12, 2016
The Risk of Specific Congenital Anomalies in Relation to Newer Antiepileptic Drugs: A Literature ReviewJosta de Jong, Ester Garne, Lolkje T W de Jong-van den Berg, et al.
Drugs - Real World Outcomes|September 23, 2017
Prescription of Sedative Drugs During Hospital Stay: A Swiss Prospective StudyLaurence Schumacher, Maria Dobrinas, Damien Tagan, et al.
Drugs - Real World Outcomes|August 6, 2017
Differences in Adverse Drug Events Among Pediatric Patients With and Without Cancer: Sub-Analysis of a Retrospective Cohort StudyAkira Koizumi, Yoshinori Ohta, Mio Sakuma, et al.
Drugs - Real World Outcomes|March 2, 2019
Epidemiological Profile of Drug Overdose Reported in South-East Morocco from 2004 to 2016Karima Azekour, Souad Belamalem, Abdelmajid Soulaymani, et al.
Drugs - Real World Outcomes|February 18, 2021
Relationship of Annual Health Checkups with the Subject's Subsequent Behavior of Cardiovascular Risk Management in a Real-World Setting in Japan: A Retrospective Cohort Study on Changes in Antihypertensive Drug Prescription and Blood Pressure from 2015 to 2017Shingo Higa, Yoichi Ii, Kazutaka Nozawa, et al.
Drugs - Real World Outcomes|February 11, 2021
Pharmacotherapy Management for COVID-19 and Cardiac Safety: A Data Mining Approach for Pharmacovigilance Evidence from the FDA Adverse Event Reporting System (FAERS)Jing Yuan, Minghui Li, Yiqun Yu, et al.
Drugs - Real World Outcomes|February 16, 2021
A Retrospective Nationwide Non-Interventional Study of an Aqueous Sublingual Immunotherapy Formulation Administered with a 200-µL Dosing PumpAlbert Roger Reig, Clara Padró Casas, Diego Gutiérrez Fernández, et al.
Drugs - Real World Outcomes|April 2, 2025
Influenza Vaccination Among Patients with Noncommunicable Diseases: A Survey About Awareness, Usage, and Unmet Needs in the Czech RepublicZdeněk Zadražil, Lenka Cesneková, Jan Kynčl, et al.
Drugs - Real World Outcomes|May 6, 2025
Real-World Clinical Characteristics, Treatment Patterns, and Clinical Outcomes in US Patients with Stage I-III Resected NSCLC Without Known EGFR Mutations: The RESECT StudyJhanelle E Gray, Rachel J Salomonsen, Ignacio Diaz Perez, et al.
Drugs - Real World Outcomes|May 29, 2025
Real-World Treatment Outcomes in Black, Hispanic, Asian, and White Patients with Multiple Sclerosis Treated with NatalizumabKaren Blitz-Shabbir, Aimee M Banks, Hina Garg, et al.
Pageof 54